Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 5/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 5/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.32 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10761390 | 0.83 | LMNA (0.39) | MEN1KMT2ALMNAALDH1A1CHRNB2 | |
| SCHEMBL11256311 | 0.82 | ALDH1A1 (0.46) | MEN1KMT2ALMNAALDH1A1CHRNB2 | |
| SCHEMBL28895591 | 0.81 | CHRNB2 (0.32) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL10633554 | 0.79 | CHRNB2 (0.35) | LMNACHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL16909986 | 0.79 | LMNA (0.50) | MEN1KMT2ALMNAALDH1A1CHRNB2 | |
| SCHEMBL11856683 | 0.79 | MEN1 (0.35) | MEN1CYP2C19RECQLKMT2ALMNA | |
| SCHEMBL10436308 | 0.78 | MEN1 (0.37) | MEN1CYP2C19RECQLKMT2ALMNA | |
| SCHEMBL10385362 | 0.77 | LMNA (0.53) | MEN1KMT2ALMNAALDH1A1 | |
| SCHEMBL5933267 | 0.77 | MEN1 (0.34) | MEN1CYP2C19RECQLKMT2ALMNA | |
| SCHEMBL11863344 | 0.77 | LMNA (0.63) | MEN1KMT2ALMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110709149-A | Method for purifying (meth) acrylic esters | 阿科玛法国公司 | 2020-01-17 | — | — | CN | disclosed |
| WO-2008155057-A2 | HYDROCARBON MIXTURE AND USE THEREOF | COGNIS IP MANAGEMENT GMBH (DE) | 2008-12-24 | — | — | WO | disclosed |
| US-7294240-B2 | Method for producing (meth)acrylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 2007-11-13 | — | — | US | disclosed |
| CN-1592734-A | Method for producing (meth)acrylic acid esters | BASF AG (DE) | 2005-03-09 | — | — | CN | disclosed |
| US-20040168903-A1 | Method for producing (meth)acrylic esters | BASF AKTIENGESELLSCHAFT (DE) | 2004-09-02 | — | — | US | disclosed |
| US-5614354-A | Method of forming positive polyimide patterns | TORAY INDUSTRIES, INC. (JP) | 1997-03-25 | — | — | US | disclosed |
| EP-0634698-A1 | PROCESS FOR FORMING POSITIVE POLYIMIDE PATTERN | TORAY INDUSTRIES, INC. (JP) | 1995-01-18 | — | — | EP | disclosed |
| US-3969322-A | AMINOESTER POLYMER FROM A NITROKETONIZED POLYMER AND TERT-AMINO ALCOHOL | TEXACO INC. (US) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040168903-A1 | Method for producing (meth)acrylic esters | ACR, MMAB, PAM | MEN1 597/4885CYP2C19 97/4885RECQL 2791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.